Thomas Bieber Selected Research

Atopic Dermatitis (Atopic Eczema)

3/2022	Altered Serum Phospholipids in Atopic Dermatitis and Association with Clinical Status.
1/2022	Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4).
1/2022	Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results.
1/2022	Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial.
1/2022	Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summary.
10/2021	Tralokinumab in atopic dermatitis.
10/2021	Serum receptor activator of nuclear factor kappa-Β ligand/osteoprotegerin ratio correlates with severity and suggests fracture's risk in older women with atopic dermatitis.
3/2021	Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial.
1/2021	Vitamin D3-Induced Promotor Dissociation of PU.1 and YY1 Results in FcεRI Reduction on Dendritic Cells in Atopic Dermatitis.
1/2021	Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Bieber Research Topics

Disease

64	Atopic Dermatitis (Atopic Eczema) 03/2022 - 03/2002
27	Inflammation (Inflammations) 05/2022 - 03/2005
14	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 03/2005
13	Pruritus (Itching) 01/2022 - 03/2002
13	Cutaneous Lupus Erythematosus 01/2021 - 03/2005
12	Eczema 01/2022 - 10/2006
10	Skin Diseases (Skin Disease) 08/2021 - 05/2004
10	Neoplasms (Cancer) 05/2021 - 04/2003
10	Hypersensitivity (Allergy) 01/2020 - 07/2004
9	Infections 08/2021 - 10/2005
8	Melanoma (Melanoma, Malignant) 01/2020 - 04/2005
7	Dermatitis 01/2020 - 10/2002
7	Asthma (Bronchial Asthma) 01/2020 - 07/2007
4	Nasopharyngitis 01/2022 - 07/2014
4	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 03/2005
3	COVID-19 01/2022 - 01/2020
3	Headache (Headaches) 01/2022 - 07/2014
3	Dermatomyositis (Dermatopolymyositis) 05/2020 - 01/2006
3	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2005
3	Virus Diseases (Viral Diseases) 05/2010 - 08/2005
3	Lichen Planus (Lichen Ruber Planus) 12/2007 - 03/2005
2	Bullous Pemphigoid (Pemphigoid) 03/2022 - 03/2005
2	Prurigo 01/2022 - 01/2020
2	Injection Site Reaction 08/2021 - 12/2016
2	Exanthema (Rash) 05/2021 - 09/2004
2	Disease Progression 04/2021 - 04/2015
2	Acne Vulgaris 01/2021 - 01/2021
2	Discoid Lupus Erythematosus 01/2021 - 01/2002
2	Rhinitis 01/2021 - 01/2016
2	Erythema 12/2020 - 07/2005
2	Urticaria (Hives) 01/2020 - 07/2011
2	Dysbiosis 01/2020 - 01/2018
2	Kaposi Varicelliform Eruption (Eczema Herpeticum) 06/2019 - 07/2008
2	Spontaneous Remission 11/2018 - 07/2005
2	Chilblain lupus 1 01/2017 - 01/2016
2	Cicatrix (Scar) 03/2011 - 06/2005
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2011 - 12/2008
2	Allergic Rhinitis 12/2009 - 10/2002
2	Basal Cell Carcinoma (Rodent Ulcer) 04/2008 - 04/2005
2	Actinic Keratosis 04/2008 - 04/2005

Drug/Important Bio-Agent (IBA)

16	Immunoglobulin E (IgE)IBA 11/2018 - 10/2002
14	CytokinesIBA 01/2020 - 10/2002
11	dupilumabIBA 01/2022 - 07/2014
11	Interleukin-13IBA 01/2021 - 10/2002
10	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 03/2002
10	AllergensIBA 11/2018 - 05/2008
9	Monoclonal AntibodiesIBA 05/2021 - 01/2006
8	Interferon Type IIBA 08/2021 - 03/2005
8	Interleukin-4 (Interleukin 4)IBA 01/2021 - 10/2002
7	LigandsIBA 10/2021 - 06/2005
7	Proteins (Proteins, Gene)FDA Link 10/2017 - 04/2005
6	Biomarkers (Surrogate Marker)IBA 05/2022 - 07/2014
6	Tacrolimus (Prograf)FDA LinkGeneric 03/2009 - 03/2002
5	abrocitinibIBA 01/2022 - 01/2020
5	AntigensIBA 10/2020 - 11/2003
5	Pharmaceutical PreparationsIBA 09/2020 - 09/2004
5	ruxolitinibIBA 05/2020 - 12/2014
5	Antiviral Agents (Antivirals)IBA 09/2019 - 07/2005
5	InterleukinsIBA 06/2019 - 10/2005
5	pimecrolimus (Elidel)FDA Link 02/2011 - 03/2005
5	Chemokine ReceptorsIBA 10/2009 - 03/2005
5	ChemokinesIBA 10/2009 - 10/2002
4	Janus KinasesIBA 01/2022 - 09/2017
4	Imiquimod (Aldara)FDA LinkGeneric 04/2021 - 01/2002
4	Immunosuppressive Agents (Immunosuppressants)IBA 03/2021 - 01/2005
4	Janus Kinase InhibitorsIBA 01/2021 - 01/2017
4	EnzymesIBA 02/2012 - 09/2004
3	VaccinesIBA 01/2022 - 08/2004
3	Immunoglobulin A (IgA)IBA 10/2021 - 09/2020
3	Janus Kinase 1IBA 01/2021 - 01/2020
3	Biological ProductsIBA 01/2021 - 01/2006
3	Nucleic AcidsIBA 01/2020 - 11/2007
3	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2016 - 01/2010
3	Calcineurin InhibitorsIBA 07/2014 - 03/2005
3	Interferon-alpha (Interferon Alfa)IBA 11/2012 - 01/2006
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2012 - 12/2007
3	Ointments (Pastes)IBA 01/2007 - 03/2002
2	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2020
2	BNT162 VaccineIBA 01/2022 - 01/2021
2	upadacitinibIBA 01/2022 - 01/2021
2	mRNA VaccinesIBA 01/2022 - 01/2021
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 03/2009
2	baricitinibIBA 01/2022 - 12/2020
2	InterferonsIBA 01/2020 - 12/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 09/2005
2	Immunologic Factors (Immunomodulators)IBA 06/2019 - 01/2003
2	Interleukin-17 (Interleukin 17)IBA 07/2018 - 04/2015
2	Filaggrin ProteinsIBA 01/2018 - 09/2008
2	Histamine (Histamine Dihydrochloride)FDA Link 09/2017 - 09/2008
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015 - 01/2014
2	Antimicrobial PeptidesIBA 07/2008 - 12/2006
2	Tryptases (Tryptase)IBA 07/2007 - 03/2007
2	IgE Receptors (Fc epsilon RI)IBA 01/2007 - 05/2002

Therapy/Procedure

23	Therapeutics 01/2022 - 05/2005
8	Immunotherapy 01/2020 - 04/2003
3	Precision Medicine 05/2022 - 01/2016
2	Contraindications 01/2022 - 03/2009
2	Lasers (Laser) 01/2021 - 03/2011
2	Injections 01/2020 - 05/2010